Gpr30 estrogen receptor in breast cancers

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01)

Patent

CA 2642419

The invention provides methods of identifying metastatic disease as well as ligands such as antibodies that bind to GPR30. These antibodies are useful in the detection or treatment of endocrine tumors.

L'invention concerne des procédés permettant d'identifier une maladie métastatique ainsi que des ligands tels que des anticorps qui se lient à GPR30. Ces anticorps sont utiles dans la détection ou le traitement de tumeurs endocrines.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gpr30 estrogen receptor in breast cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gpr30 estrogen receptor in breast cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gpr30 estrogen receptor in breast cancers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1897931

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.